ViaDerma Inc. (OTCMKTS:VDRM) Stock Soars After Successfully Accomplishes Quality Control Testing of its New Vitastem Products
ViaDerma Inc. (OTCMKTS:VDRM) announced the successful completion of the internal quality control testing for its new Vitastem products, on September 15, 2022. The testing has been implemented as an additional precautionary safeguard since products Vitastem and Vitastem Ultra are using new formulations. Trading Data On Thursday, VDRM stock surged 22.45% to $0.0120 with more than 963.07K shares, compared to its average volume of 1.79 million shares. The stock moved within…